GlassScriptPhysician profile
Jacob Nathan Blatt
NPI 1083892111
$10,042.63
in general payments reported to CMS, 2019-2025
37 companies · $1,199 in 2025
The $1,199 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,591 · 2020: $1,142 · 2021: $965 · 2022: $1,778 · 2023: $1,852 · 2024: $1,515 · 2025: $1,199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,558 · Travel and Lodging: $9.02.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,557.66 |
| Travel and Lodging | $9.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,196.39 | 2019-2025 | Advisor, Ensite, Jot Dx |
| Medtronic, INC. | $1,233.65 | 2021-2025 | Micra, Symplicity G3, Cobalt Dr Mri Surescan |
| Medtronic Vascular, INC. | $1,194.22 | 2019-2020 | |
| Boston Scientific Corporation | $791.04 | 2019-2025 | General - Brady, General - Therapies, Watchman Access System |
| Novartis Pharmaceuticals Corporation | $676.56 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $556.26 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $429.39 | 2019-2025 | Camzyos, Eliquis |
| Pfizer INC. | $405.12 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $343.90 | 2019-2025 | Lifevest |
| Amgen INC. | $272.22 | 2019-2024 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $248.79 | 2019-2024 | Jardiance |
| Abiomed | $181.40 | 2019-2024 | Impella |
| Atricure, INC. | $180.03 | 2022-2025 | Atriclip Laa Exclusion System |
| W. L. Gore & Associates, INC. | $167.09 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $144.65 | 2019-2024 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $137.79 | 2022-2023 | Assure Wcd |
| Novo Nordisk INC | $115.22 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $104.33 | 2020-2024 | Andexxa, Brilinta |
| Cvrx, INC. | $98.57 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $93.85 | 2022-2025 | Verquvo |
| Bayer Healthcare Pharmaceuticals INC. | $76.61 | 2024-2025 | |
| Imperative Care, INC | $57.88 | 2025 | Symphony Catheter |
| Heartflow, INC. | $50.37 | 2022-2024 | |
| Amarin Pharma, INC. | $39.59 | 2019 | |
| Recor Medical INC | $25.49 | 2025 | Paradise Ultrasound Renal Denervation System |
| Innovation Technologies INC | $24.73 | 2025 | Irrisept |
| Vital Connect, INC | $22.96 | 2025 | Vitalpatch Rtm |
| Osprey Medical INC | $22.00 | 2019 | |
| Daiichi Sankyo INC. | $20.91 | 2022 | |
| Lantheus Medical Imaging, INC. | $20.88 | 2019 | |
| Impulse Dynamics (USA) INC. | $20.62 | 2023 | Optimizer |
| Terumo Medical Corporation | $19.17 | 2024 | Glidewire |
| Kiniksa Pharmaceuticals, LTD. | $16.44 | 2023 | Arcalyst |
| Edwards Lifesciences Corporation | $16.15 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $15.32 | 2024 | Arcalyst |
| Chiesi USA, INC. | $11.62 | 2019 | |
| Ethicon US, LLC | $11.42 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Blatt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.